SEARCH BY
SciSparc is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. SciSparc’s focus is on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. SciSparc was formed in 2004 and is based in Tel Aviv, Israel.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Automotive M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| Country: Israel M&A | 1 of 1 |
| Year: 2024 M&A | 1 of 1 |